Background Type 1 diabetes is a metabolic disorder resulting from a defect in insulin
secretion. Onset of type 1 diabetes mellitus may occur at any age and it is one of the most …

Continuous subcutaneous insulin infusion (CSII) is used in selected type 1 diabetic subjects
to achieve strict blood glucose control. A quarter of a century after its introduction, world …

Objective: To compare glycaemic control and insulin dosage in people with type 1 diabetes
treated by continuous subcutaneous insulin infusion (insulin infusion pump therapy) or …

Background Diabetes results in a rise in blood glucose above normal physiological levels; if
untreated this may cause damage to many systems including the cardiovascular and renal …

Aims/hypothesis The aim of the study was to analyse the insulin requirements of women with
type 1 diabetes mellitus throughout pregnancy. Methods We have examined the weekly …

В руководстве обобщены наиболее современные представления об этиологии,
патогенезе, диагностике, профилактике и лечении, а также возможностях медико …

OBJECTIVE—In pregnancy with type 1 diabetes, we evaluated occurrence of mild and
severe hypoglycemia and analyzed the influence of strict metabolic control, nausea …

There is strong evidence that the avoidance of hyperglycemia is essential inoptimizing
pregnancy outcome in type 1 diabetes. The price to pay is a striking increase in severe …

The objective of the study was to study the effects of continuous subcutaneous insulin
infusion (CSII) vs multiple-dose insulin (MDI) therapy on glycemic control and pregnancy …

Objectives: To assess the clinical and cost-effectiveness of continuous subcutaneous insulin
infusion (CSII) compared with multiple daily injections (MDI) in the delivery of intensive …